NFKB1 and breast cancer: Similarly to the observations performed in immunologic settings, overexpression of miR-146a/b in the highly metastatic human breast cancer cell line MDA-MB-231 significantly downregulated expression of IRAK1 and TRAF6, negatively regulating NF-κB activity [18].